Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Antibiotic Prophylaxis in Patients Undergoing Elective Total Knee Arthroplasty
NCT03283878Phase 4Completed
- Sponsor
- Duke University
- Start
- Oct 2017
- Primary completion
- Nov 2024
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of cefazolin in periprosthetic joint infection (PJI), sponsored by Duke University. Started Oct 2017; status: completed.
02
Drugs
cefazolin
03
Conditions
periprosthetic joint infection (PJI)
Beyond the preview
Go deeper on NCT03283878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03283878.